ARK Genomic Revolution ETF vs Hims and Hers Health Inc — how do they compare? ARK Genomic Revolution ETF trades at $44.8, while Hims and Hers Health Inc trades at $30.79 (market cap $7.12B). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Hims and Hers Health Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | HIMS | |
|---|---|---|
Sector | Sector/Thematic | Health |
52-Week High | $44.55 | $62.76 |
52-Week Low | $24.02 | $14.52 |
Market Cap | — | $7.12B |
Enterprise Value | — | $7.82B |
Trailing returns across standard periods
Latest headlines on both assets
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.
Read more on HIMS →